AI Reputation Analysis and Signal Evaluation – Pulmozyme (Genentech)

B
Reputation Level
Medical Devices, Pharma & Biotech
59.3 Avg Reputation

Based on 784 businesses audited.

Brand AI Reputation

Medical Devices, Pharma & Biotech Reputation: Pulmozyme (Genentech) (pulmozyme.com)

https://pulmozyme.com 📍 Industry: Medical Devices, Pharma & Biotech
77 Reputation / 100

This is a low-BS, highly regulated pharmaceutical site that prioritizes clinical data and technical specifications over marketing fluff. Its only ‘bullshit’ is the repetitive use of high-level marketing slogans in headers to frame the dense medical content. It serves as a benchmark for Substance-First communication in the sector.

Info Density Power-words vs. Substance ratio.
24 80% Reputation
View evidence →
Semantic Coherence Homepage promise vs. Sub-page reality.
20 100% Reputation
View evidence →
Trust & Proof Verifiable evidence vs. Trust Theatre.
9 45% Reputation
View evidence →
Commodity Fingerprint Detection of industry clichés/templates.
10 67% Reputation
View evidence →
Identity & Authority Expert verifiability & Schema depth.
14 93% Reputation
View evidence →

Medical Devices, Pharma & Biotech Reputation: Pulmozyme (Genentech) (pulmozyme.com)

Reputation: 77 / 100

Pulmozyme is a textbook pharmaceutical product site. The content strictly adheres to FDA-regulated communication patterns, focusing on Indication, Usage, and Safety Information (ISI).

“The score of 77 is primarily driven by Step 3's Trust Theatre and Step 4's Industry Cliché Density. The lack of direct external proof links for clinical trials and the use of unverified review counts contributed 11 points. Information density deductions were minimal, reflecting the site's high technical specificity.”

Verified Analysis Date: June 19, 2026 © 1EuroSEO Independent Evaluator — Non-Sponsored Result